Cargando…

The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke

BACKGROUND: Reactive astrogliosis is one of the significantly pathological features in ischemic stroke accompanied with changes in gene expression, morphology, and proliferation. KCa3.1 was involved in TGF-β-induced astrogliosis in vitro and also contributed to astrogliosis-mediated neuroinflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Mengni, Wei, Tianjiao, Wang, Yanxia, Lu, Qin, Chen, Gaoxian, Gao, Xiaoling, Geller, Herbert M., Chen, Hongzhuan, Yu, Zhihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644250/ https://www.ncbi.nlm.nih.gov/pubmed/29037241 http://dx.doi.org/10.1186/s12974-017-0973-8

Ejemplares similares

The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer’s Disease
por: Wei, Tianjiao, et al.
Publicado: (2017)

KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways
por: Yu, Zhihua, et al.
Publicado: (2017)

Ca(2+)-dependent endoplasmic reticulum stress correlation with astrogliosis involves upregulation of KCa3.1 and inhibition of AKT/mTOR signaling
por: Yu, Zhihua, et al.
Publicado: (2018)

Functional Cooperation between KCa3.1 and TRPV4 Channels in Bronchial Smooth Muscle Cell Proliferation Associated with Chronic Asthma
por: Yu, Zhihua, et al.
Publicado: (2017)

The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson’s disease
por: Lu, Jia, et al.
Publicado: (2019)

Histidine phosphorylation relieves copper inhibition in the mammalian potassium channel KCa3.1
por: Srivastava, Shekhar, et al.
Publicado: (2016)

The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury
por: Sevelsted Møller, Linda, et al.
Publicado: (2016)

Contribution of the KCa3.1 channel–calmodulin interactions to the regulation of the KCa3.1 gating process
por: Morales, Patricia, et al.
Publicado: (2013)

Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma
por: Catacuzzeno, Luigi, et al.
Publicado: (2012)

Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1
por: Ji, Tianyang, et al.
Publicado: (2018)

Correction: Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1
por: Ji, Tianyang, et al.
Publicado: (2018)

Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo
por: Bachmann, Magdalena, et al.
Publicado: (2022)

The intermediate‐conductance calcium‐activated potassium channel KCa3.1 contributes to alkalinization‐induced vascular calcification in vitro
por: Bai, Yaling, et al.
Publicado: (2021)

Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions
por: Chiang, Eugene Y., et al.
Publicado: (2017)

Ca(2+)-activated KCa3.1 potassium channels contribute to the slow afterhyperpolarization in L5 neocortical pyramidal neurons
por: Roshchin, M. V., et al.
Publicado: (2020)

Characterization of the PCMBS-dependent modification of KCa3.1 channel gating
por: Bailey, Mark A., et al.
Publicado: (2010)

KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo
por: D'Alessandro, G, et al.
Publicado: (2013)

KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
por: Brown, Brandon M., et al.
Publicado: (2018)

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3
por: Oliván-Viguera, Aida, et al.
Publicado: (2013)

The Long Non-Coding RNA-14327.1 Promotes Migration and Invasion Potential of Endometrial Carcinoma Cells by Stabilizing the Potassium Channel Kca3.1
por: Zhang, Yingli, et al.
Publicado: (2019)

KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
por: D'Alessandro, Giuseppina, et al.
Publicado: (2016)

LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells
por: Caglioti, Concetta, et al.
Publicado: (2022)

Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2018)

Investigating CFTR and KCa3.1 Protein/Protein Interactions
por: Klein, Hélène, et al.
Publicado: (2016)

Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019)

Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease
por: Maezawa, Izumi, et al.
Publicado: (2012)

KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis
por: Anumanthan, Govindaraj, et al.
Publicado: (2018)

Involvement of KCa3.1 channel activity in immediate perioperative cognitive and neuroinflammatory outcomes
por: Saxena, Sarah, et al.
Publicado: (2023)

KCa3.1 as an Effective Target for Inhibition of Growth and Progression of Intrahepatic Cholangiocarcinoma
por: Song, Penghong, et al.
Publicado: (2017)

KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis
por: Huang, Chunling, et al.
Publicado: (2014)

Radiation Increases Functional KCa3.1 Expression and Invasiveness in Glioblastoma
por: D’Alessandro, Giuseppina, et al.
Publicado: (2019)

Modulation of Retrograde Trafficking of KCa3.1 in a Polarized Epithelium
por: Lee, Bob Shih-Liang, et al.
Publicado: (2017)

KCa3.1 Impairment Is Not Just a Slow Afterthought in Epilepsy
por: Gross, Christina
Publicado: (2020)

Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat
por: Khaddaj Mallat, Rayan, et al.
Publicado: (2019)

KCa3.1 and TRPM7 Channels at the Uropod Regulate Migration of Activated Human T Cells
por: Kuras, Zerrin, et al.
Publicado: (2012)

Functional Roles of the Ca(2+)-activated K(+) Channel, KCa3.1, in Brain Tumors
por: D’Alessandro, Giuseppina, et al.
Publicado: (2018)

High Glucose Induces CCL20 in Proximal Tubular Cells via Activation of the KCa3.1 Channel
por: Huang, Chunling, et al.
Publicado: (2014)

The Blockage of KCa3.1 Channel Inhibited Proliferation, Migration and Promoted Apoptosis of Human Hepatocellular Carcinoma Cells
por: Liu, Yu, et al.
Publicado: (2015)

KCa3.1 Mediates Dysregulation of Mitochondrial Quality Control in Diabetic Kidney Disease
por: Huang, Chunling, et al.
Publicado: (2021)

Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair
por: Girault, Alban, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7c2jkkb7ih7j34qmjlk2erh6nk